Therapy-free interval has prognostic value in patients with recurrent cervical cancer treated with chemotherapy following definitive concurrent chemoradiotherapy-Reference-Cited by-同舟云学术

Therapy-free interval has prognostic value in patients with recurrent cervical cancer treated with chemotherapy following definitive concurrent chemoradiotherapy

Published:2017-09-07 Issue:5 Volume:296 Page:997-1003
ISSN:0932-0067
Container-title:Archives of Gynecology and Obstetrics
language:en
Short-container-title:Arch Gynecol Obstet

Author:

Kozaki Mitsuru,Sakuma Saki,Kudaka Wataru,Kinjyo Yoshino,Taira Yusuke,Arakaki Yoshihisa,Shimoji Yuko,Nakasone Tadaharu,Nakamoto Tomoko,Wakayama Akihiko,Ooyama Takuma,Aoki Yoichi^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology,General Medicine

Link

http://link.springer.com/article/10.1007/s00404-017-4520-8/fulltext.html

Reference23 articles.

1. Cancer IAfRo (2017) Cervical cancer estimated incidence, mortality and prevalence worldwide in 2012. http://globocan.iarc.fr/old/FactSheets/cancers/cervix-new.asp . Accessed 25 July 2017

2. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA et al (1999) Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340:1144–1153

3. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL 3rd et al (1999) Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340:1154–1161

4. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE et al (1999) Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340:1137–1143

5. Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC Jr et al (1999) Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17:1339–1348

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating cat boost algorithm with triangulating feature importance to predict survival outcome in recurrent cervical cancer;Scientific Reports;2024-08-27

2. Late recurrence of locally advanced cervical cancer treated with concurrent chemoradiotherapy;Oncology in Clinical Practice;2022-12-21

3. The role of selenoprotein P in the determining the sensitivity of cervical cancer patients to concurrent chemoradiotherapy: A metabonomics-based analysis;Journal of Trace Elements in Medicine and Biology;2022-09

4. Prognostic factors for post-recurrence survival among patients with locally advanced cervical cancer who underwent definitive concurrent chemoradiation;Reports of Practical Oncology and Radiotherapy;2022-07-06

5. Clinical outcomes of uterine arterial chemoembolization with drug-eluting beads for advanced-stage or recurrent cervical cancer;Abdominal Radiology;2021-09-02